Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Rubius Therapeutics Inc.

    NASDAQ: RUBY · Real-Time Price · USD
    0.06
    0.00 (8.11%)
    At close: Dec 29, 2023, 8:49 PM

    Rubius Therapeutics Revenue

    Rubius Therapeutics reported an annual revenue of $0, reflecting a 0% growth. For the quarter ending December 31, 2022, Rubius Therapeutics generated $0 in revenue.
    Revenue (ttm)
    $0
    Revenue Growth
    0%
    Price / Sales Ratio
    0
    Revenue / Employee
    $0
    Employees
    6
    Market Cap
    0

    Revenue Chart

    Revenue History

    Fiscal Year End Revenue % Change
    Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

    Add to Watchlist